Core Insights - The trend in medical device development is shifting towards digitalization, intelligence, and precision, with innovative products debuting at the China International Import Expo (CIIE) [1] - China is increasingly recognized as a major player in the global medical innovation ecosystem, with many multinational pharmaceutical and medical device companies leveraging the CIIE platform to introduce innovative medical products and technologies [1] Group 1: Innovative Products - EssilorLuxottica will showcase the Nuance Audio smart hearing glasses, designed for individuals with mild to moderate hearing loss, integrating advanced open-ear hearing technology into eyewear [3] - Siemens Healthineers will present a high-gradient magnetic resonance device that aids Neuralink in brain-machine interface clinical trials, transitioning invasive surgeries from "blind insertion" to a more visible and controlled process [4] - Johnson & Johnson will debut the Impella artificial heart product, the only FDA-approved left ventricular assist device, which has been used in over 400,000 cases globally [4] Group 2: Market Statistics and Projections - According to the China Hearing Health Management Association, over 33% of individuals aged 65 and above in China suffer from moderate to severe hearing loss, affecting more than 120 million elderly people [3] - The Impella device and its accompanying host have received approval for clinical use in the Guangdong-Hong Kong-Macao Greater Bay Area, allowing for early patient treatment [5] - The ChondroFiller Liquid product, designed for cartilage regeneration, has been used in over 21,000 cases across Asia and Europe, and is now included in the medical insurance reimbursement list in the Greater Bay Area [6]